This study investigates the use of an investigational medication for patients with anemia who are undergoing hemodialysis due to chronic kidney disease. Anemia is a condition where the body does not have enough healthy red blood cells. The purpose of this study is to see how safe the investigational medication is and how it affects blood markers related to anemia.
Participants will receive the investigational medication through repeated intravenous (IV) infusions. The study will monitor the safety and tolerability of these infusions and observe any changes in blood markers. An IV infusion is a way to deliver medicine directly into the bloodstream.
- Who can participate: Adults aged 18 and over with chronic kidney disease who are anemic and undergoing hemodialysis may be eligible to participate.
- Study details: Participants will receive repeated intravenous infusions of the investigational medication. The study will focus on monitoring safety and changes in blood markers related to anemia.
